Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-006735
Filing Date
2025-03-07
Accepted
2025-03-07 21:09:50
Documents
2
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5642
2 poa_acittadine.htm EX-24 4352
  Complete submission text file 0001437749-25-006735.txt   11388
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address
Cittadine Andrew (Reporting) CIK: 0001863624 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39070 | Film No.: 25721915